Hypertensive crisis resident survival guide

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

Definitions

  • Hypertensive urgencies - These are severe elevations in blood pressure with no or minimal evidence of target organ damage.[1] An example is a blood pressure of greater than 160/100 mmHg (stage 2 hypertension) associated with severe headache, shortness of breath, nosebleeds, or severe anxiety.
  • Hypertensive emergencies - These are severe elevations in blood pressure, usually greater than 180/120 mmHg, complicated by evidence of impending or progressive target organ dysfunction. They warrant urgent blood pressure reduction by parenteral agents to prevent or limit target organ damage.[1] This is a clinical diagnosis. Examples include: hypertensive encephalopathy, intracerebral hemorrhage, acute myocardial infarction, e.t.c.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Management

 
 
 
 
Characterize the symptoms:
❑ CNS - severe headache, dizziness, confusion, weakness/numbness, altered/LOC, difficulty speaking
❑ Eyes - pain, blurred/loss of vision
❑ Cardiopulmonary - chest pain, dyspnea
❑ Renal - hematuria, proteinuria, reduced urinary output
❑ Others - nausea/vomiting, severe anxiety, nosebleeds
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluate the patient:
❑ History
PMH especially HTN
Medications - dosages, compliance
Recreational drug use - methamphetamine, cocaine, phencyclidine
❑ Physical
Blood pessure - both arms
Fundoscopy - papilledema, exudates, hemorrhages
Neuro exam - mental status, focal neurological deficits
Cardiopulmonary - signs of pulmonary edema
Abdomen - pulsatile masses, tenderness, bruits
Limbs - peripheral pulses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Order Labs:
❑ CBC
❑ BMP + Mg + PO4
❑ Serum uric acid
❑ FLP
❑ FBS
❑ Urinalysis/culture
❑ Urine electrolytes, creatinine, protein
❑ Chest X-ray
❑ EKG, ECHO
❑ Renal USS + doppler
 
Further work-up:
❑ TSH, free T3, free T4
❑ Serum cortisol
❑ Serum aldosterone
❑ Serum renin levels
❑ HbA1C
❑ 24-hr urinary catecholamine & metanephrine levels
❑ Serum parathyroid hormone levels
❑ Urine and serum toxicology screen
❑ Urine pregnancy test
❑ CT/MRI
❑ DMSA/DTPA scans (renal scars)
❑ ANA/ESR/CRP/anti-dsDNA/anti-smith/rheumatoid factor/p-ANCA/c-ANCA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evidence of end organ damage (any of the symptoms above)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YES
 
 
 
 
 
NO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypertensive emergency
(NB - Treat the patient and not the BP)
 
 
 
 
 
Hypertensive urgency
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Admit ICU
Close BP monitoring

Intra-arterial BP monitoring in severely-ill patients

Assess volume status - IV N/S if volume depleted to prevent precipitous fall in BP following administration of antihypertensives

Commence IV antihypertensives based on patient's symptom

Change IV meds to oral when BP is stable
NB - Not more than 25% reduction in BP within the 1st hour; when BP is stable, reduce to 160/100-110 mmHg within the next 2-6 hours
 
 
 
 
 
 
Outpatient/Admit for observation
Oral antihypertensives
Clinical surveillance within the first few hours of commencing medications
NB - Gradual BP reduction over 24 - 48 hours
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Special considerations
Malignant hypertension/Hypertensive encephalopathy
Cerebrovascular accident
Acute pulmonary edema
Acute aortic dissection
Angina pectoris/Acute MI
Sympathetic crisis
Preeclampsia/Eclampsia
Withdrawal of antihypertensive medication
Acute post-op hypertension
 
 
 
 
Worsening blood pressure
 
Good control
Review old/start new medication
Modify risk factors
Close follow-up
 
 
 

Dos

Don'ts

References

  1. 1.0 1.1 Chobanian, AV.; Bakris, GL.; Black, HR.; Cushman, WC.; Green, LA.; Izzo, JL.; Jones, DW.; Materson, BJ.; Oparil, S. (2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199. Unknown parameter |month= ignored (help)

Template:WH Template:WS